Professor David Kavanagh of Newcastle University has been selected to deliver the Chandos Lecture at UK Kidney Week 2026, recognising his world-leading contribution to the understanding and treatment of complement-mediated kidney disease.

The Chandos Lecture, established in 1976, reflects the longstanding commitment of the Chandos family to advancing kidney care and research in the UK. It honours authoritative work across the full spectrum of kidney disease and is delivered annually at the UK Kidney Association’s flagship conference, UK Kidney Week.

Professor Kavanagh is Director of the National Renal Complement Therapeutics Centre and an internationally recognised authority on complement biology in kidney disease. His work has defined how genetic and acquired complement dysregulation underpins conditions such as atypical haemolytic uraemic syndrome and C3 glomerulopathy.

His research has shaped diagnostic pathways, informed genetic screening strategies and guided the clinical use of complement inhibitors in the UK and internationally. With more than 200 peer-reviewed publications, including recent work in The Lancet, his career exemplifies translational nephrology, linking mechanism to medicine.

An experienced and highly regarded speaker, Professor Kavanagh is known for his ability to explain complex biological systems clearly and connect them directly to clinical care across the multi-professional kidney workforce.

Professor Kavanagh’s selection to deliver the Chandos Lecture reflects both the scientific depth of his work and its lasting impact on kidney care, aligning closely with the purpose and tradition of the lecture.

The lecture will be delivered in person during the morning plenary at UK Kidney Week 2026, taking place at 8:30 am on Thursday 12 March 2026 in Harrogate.